We are aware of current issues with the ONS login and account creation. At this time, account creation is unavailable. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Tanezumab
Tanezumab is a monoclonal antibody that targets nerve growth factor, potentially affecting how the body processes pain. Tanezumab has been examined for its effect on pain.